What is NDC 70954-881?

70954-881 is the product NDC for Anagrelide, Anagrelide hydrochloride 1 mg/1 capsule, listed with the FDA by ANI Pharmaceuticals, Inc.. It has 1 package NDC, shown above in 10- and 11-digit form.

ANI Pharmaceuticals, Inc., NDC labeler code 70954. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.

What other NDCs exist for Anagrelide?

5 other product NDCs are listed under this name.

Is there a related HCPCS / J-code?

Not in Med-Code's curated HCPCS directory.

Anagrelide NDC 70954-881 | National Drug Code

NDC codes

FDA NDC Directory

Product NDC (as listed)70954-881Labeler and product segments. Claims need a package NDC.

Product NDC at billing width70954-0881Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
70954-881-10	70954088110	100 CAPSULE in 1 BOTTLE (70954-881-10)Marketed from Nov 6, 2025

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Anagrelide
Generic name (nonproprietary): anagrelide
Active ingredients: Anagrelide hydrochloride — 1 mg/1
Dosage form: Capsule
Route: Oral
Labeler: ANI Pharmaceuticals, Inc.NDC labeler code 70954
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 076811
Marketing start: Nov 6, 2025
Listing expires: Dec 31, 2027
Other FDA classes: Decreased Platelet Production (Physiologic effect)Phosphodiesterase 3 Inhibitors (Mechanism)
Identifiers: Product ID 70954-881_325cc1f1-dbf1-430f-921b-a759a5e97b56SPL ID 325cc1f1-dbf1-430f-921b-a759a5e97b56SPL set ID 56b3959d-4b6b-413f-b753-9d4c20c07466RxCUI 597850, 597852UNII YTM763Y5C8
Pharmacologic class: Platelet-reducing Agent

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N470954088110 followed by a unit qualifier and the quantity

Package 70954-0881-10. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Jul 10, 2026.

Indications (excerpt from the label)

Anagrelide capsules are indicated for the treatment of patients with thrombocythemia, secondary to myeloproliferative neoplasms, to reduce the elevated platelet count and the risk of thrombosis and to ameliorate associated symptoms including thrombo-hemorrhagic events. Anagrelide is a platelet reducing agent indicated for the treatment of thrombocythemia, secondary to myeloproliferative neoplasms, to reduce the elevated platelet count and the risk of thrombosis and to ameliorate associated symptoms including thrombo-hemorrhagic events. (1)

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

About NDC 70954-881

What is NDC 70954-881?: 70954-881 is the product NDC for Anagrelide, Anagrelide hydrochloride 1 mg/1 capsule, listed with the FDA by ANI Pharmaceuticals, Inc.. It has 1 package NDC, shown above in 10- and 11-digit form.
What drug is associated with this NDC?: Anagrelide.
What is the active ingredient?: Anagrelide hydrochloride.
Who is the labeler?: ANI Pharmaceuticals, Inc., NDC labeler code 70954. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for Anagrelide?: 5 other product NDCs are listed under this name. See all Anagrelide NDCs.
Is there a related HCPCS / J-code?: Not in Med-Code's curated HCPCS directory. See Billing references above.

Other finished products listed under the same name: strengths, forms and labelers.

Other Anagrelide NDCs
Product	Strength	Form · route	Labeler	Product NDC	Package NDCs (11-digit)
Anagrelide	Anagrelide hydrochloride .5 mg/1	CapsuleOral	ANI Pharmaceuticals, Inc.	70954-879	70954-0879-10
anagrelide	Anagrelide hydrochloride anhydrous .5 mg/1	CapsuleOral	Torrent Pharmaceuticals Limited	13668-453	13668-0453-0113668-0453-30
anagrelide	Anagrelide hydrochloride anhydrous 1 mg/1	CapsuleOral	Torrent Pharmaceuticals Limited	13668-462	13668-0462-0113668-0462-30
Anagrelide	Anagrelide hydrochloride anhydrous 1 mg/1	CapsuleOral	Chartwell RX, LLC	62135-313	62135-0313-60
Anagrelide	Anagrelide hydrochloride anhydrous .5 mg/1	CapsuleOral	Chartwell RX, LLC	62135-312	62135-0312-12

Other NDCs under ANDA 076811

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 076811
Product	Strength	Form · route	Labeler	Product NDC
Anagrelide	Anagrelide hydrochloride .5 mg/1	CapsuleOral	ANI Pharmaceuticals, Inc.	70954-879